Below are some training materials related to the effects of tobacco use in various populations. This includes presentations by Dr. Okoli, BH WELL's "Lunch and Learn" spring 2022 webinar series, and a testimonial of a teenage Juul user from North Carolina.
Dr. Lee Anne Walmsley hosted this virtual seminar on March 16, 2022 as a part of BH WELL's "Lunch and Learn" series. Her presentation titled, "Motivational Interviewing and Behavioral Counseling For Those With A Mental Illness: Skills To Enhance Therapeutic Engagement" was followed by 15 minutes of Q&A.
Dr. Zim Okoli hosted a presentation titled, "Tobacco Use and Mental Illness: Addressing the Hidden Epidemic" in a BH WELL monthly lunchtime seminar via Zoom on January 19, 2022, from 12-1 PM EST. This 30-minute teaching was followed by 30 minutes of Q&A.
Dr. Zim Okoli created this presentation to address tobacco treatment policies in behavioral health settings. The presentation explores a logic model for implementing and evaluating processes needed to provide a healthy environment to achieve wellness and recovery goals by de-normalizing tobacco use and promoting tobacco cessation.
This presentation by Dr. Zim Okoli discusses Tobacco Treatment and Mental Illness. It outlines a brief background on tobacco product use, discusses the tobacco use epidemic among people with mental illness (MI), and reports behavioral treatment considerations and pharmacotherapy for tobacco treatment among people with MI.
Luka Kinard became addicted to Juul when he was 14. Now 17 years old, he shares his story in hopes of helping others who are also fighting Juul addiction. Hear the conversation (about 45 minutes) between Luka and his mom, Kelly, where they discuss Luka’s journey with Juul addiction and how he has battled his addiction (and continues to daily) in exchange for getting his life back.
These five simulated scenario videos depicts a clinician and a patient living with either major depressive disorder, frequent alcohol use, Substance Use Disorder, ADHD, or schizophrenia. The clinician aids the patient in stopping tobacco use by employing the 5A's: Ask, Advise, Assess, Assist, Arrange. Individuals living with major depressive disorder use tobacco at a disproportionately greater rate compared to the general population.
This presentation focuses on tobacco use in populations living with mental illness. It discusses the importance of recognizing tobacco treatment in the behavioral health population as normal. The tobacco companies have worked for years to target individuals living with mental illness, using psychology to market tobacco use as a way of coping and belonging while pocketing $37 billion from people living with mental illness who use tobacco products. Nicotine addiction is treatable in individuals living with mental and behavioral health challenges. While conventional methods of tobacco cessation do not work with this population, there are ways to tailor tobacco treatment so that it can be effective for individuals living with mental illness.